Kemper Corporation 5.875% Fixed (KMPB) Stock Price & Analysis
Kemper Corporation 5.875% Fixed (KMPB) is trading at USD 24.9, down 0.16% today, as of October 23, 2026 at 16:56 UTC (US market open; quotes may be delayed), according to Nexqual market data.
KMPB last closed at USD 24.94; today's session has ranged USD 24.85–24.94 on volume of 13,123 shares. Market capitalization is —, with a 52-week range of USD 22.03–24.95 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 17:01 UTC.
Also available as compact Markdown for AI agents: nexqual.com/KMPB.md
Key facts (KMPB)
- Last four reported quarters (through Jun 30, 2026): revenue $4.57B, net income -$496M (-10.8% margin), free cash flow $397M (SEC filings).
- Insider open-market purchases, last ~7 months: 5 Form 4 filings, $368K; 0 by opportunistic insiders, 0 by routine insiders.
- Total return with dividends: 1Y +11.7% vs S&P 500 +14.6%; 5Y +33.0% vs S&P 500 +77.3%.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (KMPB)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.72B | $5.52B | $4.94B | $4.64B | $4.79B | $4.57B |
| Operating income | -$334M | -$167M | -$68.9M | — | — | — |
| Net income | -$124M | -$287M | -$272M | $318M | $143M | -$496M |
| EPS (diluted) | -$1.92 | -$4.50 | -$4.25 | $4.91 | $2.29 | — |
| Free cash flow | $293M | -$241M | -$188M | $330M | $554M | $397M |
| Operating margin | -5.8% | -3.0% | -1.4% | — | — | — |
| Net margin | -2.2% | -5.2% | -5.5% | 6.9% | 3.0% | -10.8% |
| Revenue growth | +9.9% | -3.4% | -10.5% | -6.2% | +3.3% | — |
| Cash + short-term investments | — | $491M | $585M | $1.10B | $440M | — |
| Total debt | $1.12B | $1.39B | $1.39B | $1.39B | $944M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (KMPB)
P/E at fiscal year-ends: Dec 2025 10.2x, Dec 2024 4.8x.
Insider purchases (SEC Form 4, open-market, last ~7 months) (KMPB)
5 purchases, $368K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-13 | McAnena Stephen J | President and CEO | 3,000 | $80K | 26.5 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11 | Evans Carl Thomas Jr. | EVP, Sec. & General Counsel | 1,000 | $27K | 26.53 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11 | Camden Bradley T | EVP and CFO | 1,000 | $26K | 26.34 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11 | Laderman Gerald | Director | 4,000 | $106K | 26.49 | Too little history (no open-market trades in 2023) |
| 2026-08-10 | Gorevic Jason N | Director | 5,000 | $130K | 25.91 | Too little history (no open-market trades in 2023 or 2024) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Total return (dividends reinvested) (KMPB)
| 1Y (from 2025-10-23) | 5Y (from 2022-03-14) | |
|---|---|---|
| Total return | +11.7% | +33.0% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | +11.7% | +6.4% |
| Volatility (annualized) | 7.0% | 16.7% |
| Max drawdown | -6.2% (Feb 2026→Mar 2026) | -27.7% (Aug 2022→May 2023) |
Companies that name KMPB in their SEC reports
| Relationship to KMPB | Company | Filing | Sentence |
|---|---|---|---|
| partner | Oaktree Specialty Lending Corp (OCSL) | 10-K Nov 18, 2025 | “These included debt investments in 124 companies, equity investments in 35 companies and our investments in Senior Loan Fund JV I, LLC, or SLF JV I, a joint venture through which we and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation, or Kemper, co-invest in senior secured loans of middle-market companies and other corporate debt securities, and OCSI Glick JV LLC, or the Glick JV, a joint v…” |
KMPB company outlook (results filed Aug 5, 2026)
- “Kemper assumes no obligation to publicly correct or update any forward-looking statements as a result of events or developments subsequent to the date of this press release. 15 ### Contacts Investors: Michael Marinaccio 312.661.4930 or investors@kemper.com Media: Barbara Ciesemier 312.661.4521 or bciesemier@kemper.com 16”
Quoted word-for-word from the SEC 8-K results press release.
Key Statistics (as of October 23, 2026 at 17:01 UTC)
| Price | USD 24.9 |
|---|---|
| Change | ▼ 0.16% (down) |
| Previous Close | USD 24.94 |
| Open | USD 24.86 |
| Day Range | USD 24.85 – 24.94 |
| 52-Week Range | USD 22.03 – 24.95 |
| Volume | 13,123 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (KMPB)
Nexqual's technical model rates KMPB "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of October 23, 2026 at 17:01 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.17 (neutral) |
| vs SMA50 | Above (USD 24.67) |
| MACD | 0.06 (positive) |
Earnings (KMPB)
Source: Nexqual, October 23, 2026 at 17:01 UTC.
Financial Health Score (KMPB)
Nexqual rates Kemper Corporation 5.875% Fixed's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 17:01 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — $389M cash and investments vs $944M debt (Mar 2026, SEC) |
| Cash Flow | Solid — FCF $397M (last 4 quarters to Jun 2026, SEC), 9% margin |
| Efficiency | Mixed — No data |
From Kemper Corporation 5.875% Fixed's Latest SEC 10-K Filing (filed 2026-02-11)
Partnerships
- Premiums for life insurance products are based on assumptions with respect to mortality, morbidity, investment yields, expenses, and lapses and are also affected by state laws and regulations, as well as competition.
Legal & Regulatory Risks (Item 1A, quoted)
- Kemper's insurance subsidiaries are subject to significant regulation, and the evolving legal and regulatory landscape in which they operate could result in increased operating costs, reduced profitability and limited growth.
- Legal and regulatory proceedings are unpredictable and could produce one or more unexpected outcomes that could materially and adversely affect the Company's financial results for any given period.
- Changes in the availability of insurance coverage or in the ability of insurers to meet their obligations could result in the Company being exposed to significant losses.
- The Company could be adversely affected by future changes in U.S. Federal or Bermuda income tax laws.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKHCF | Sonic Healthcare Ltd. | USD 13 | ▲ 0% |
| EBCOY | Ebara Corp. | USD 12.02 | ▲ 0.17% |
| INTJ | Intelligent Group Limited | USD 3.19 | ▲ 6.51% |
| CLPXY | China Longyuan Power Group | USD 6.65 | ▼ 0% |
| WRDLY | Worldline SA | USD 6.75 | ▲ 3.69% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:01 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt